Ergosterol distribution controls surface structure formation and fungal pathogenicity
Open Access
- 6 July 2023
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 14 (4) , e0135323
Abstract
Ergosterol, the major sterol in fungal membranes, is critical for defining membrane fluidity and regulating cellular processes. Although ergosterol synthesis has been well defined in model yeast, little is known about sterol organization in the context of fungal pathogenesis. We identified a retrograde sterol transporter, Ysp2, in the opportunistic fungal pathogen Cryptococcus neoformans . We found that the lack of Ysp2 under host-mimicking conditions leads to abnormal accumulation of ergosterol at the plasma membrane, invagination of the plasma membrane, and malformation of the cell wall, which can be functionally rescued by inhibiting ergosterol synthesis with the antifungal drug fluconazole. We also observed that cells lacking Ysp2 mislocalize the cell surface protein Pma1 and have abnormally thin and permeable capsules. As a result of perturbed ergosterol distribution and its consequences, ysp2 ∆ cells cannot survive in physiologically relevant environments such as host phagocytes and are dramatically attenuated in virulence. These findings expand our knowledge of cryptococcal biology and underscore the importance of sterol homeostasis in fungal pathogenesis. IMPORTANCE: Cryptococcus neoformans is an opportunistic fungal pathogen that kills over 100,000 people worldwide each year. Only three drugs are available to treat cryptococcosis, and these are variously limited by toxicity, availability, cost, and resistance. Ergosterol is the most abundant sterol in fungi and a key component in modulating membrane behavior. Two of the drugs used for cryptococcal infection, amphotericin B and fluconazole, target this lipid and its synthesis, highlighting its importance as a therapeutic target. We discovered a cryptococcal ergosterol transporter, Ysp2, and demonstrated its key roles in multiple aspects of cryptococcal biology and pathogenesis. These studies demonstrate the role of ergosterol homeostasis in C. neoformans virulence, deepen our understanding of a pathway with proven therapeutic importance, and open a new area of study.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI140979)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI178330)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI135012)
- HHS | NIH | National Institute of General Medical Sciences (GM007067)
This publication has 76 references indexed in Scilit:
- Cryptococcus neoformans Rim101 Is Associated with Cell Wall Remodeling and Evasion of the Host Immune ResponsesmBio, 2013
- Amphotericin primarily kills yeast by simply binding ergosterolProceedings of the National Academy of Sciences, 2012
- Ergosterol Regulates Sterol Regulatory Element Binding Protein (SREBP) Cleavage in Fission YeastJournal of Biological Chemistry, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Conservation of the Sterol Regulatory Element-Binding Protein Pathway and Its Pathobiological Importance in Cryptococcus neoformansEukaryotic Cell, 2009
- Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans2009
- Sterol transport in yeast and the oxysterol binding protein homologue (OSH) familyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Sterol-Rich Plasma Membrane Domains in FungiEukaryotic Cell, 2007
- Loss of cell wall alpha(1‐3) glucan affects Cryptococcus neoformans from ultrastructure to virulenceMolecular Microbiology, 2006
- Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein–related proteins and phosphoinositidesJournal of Cell Biology, 2006